|

Spatially Fractionated Radiotherapy for Tumor Treatment

RECRUITINGPhase 1/2Sponsored by Xu Zhi-yuan
Actively Recruiting
PhasePhase 1/2
SponsorXu Zhi-yuan
Started2024-12-19
Est. completion2028-12
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07774819

Summary

To explore the efficacy and toxicity of spatially fractionated radiotherapy in the treatment of tumors.

Eligibility

Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients with a bulky solid tumor with a maximum diameter \>4 cm or a refractory solid tumor.

Exclusion Criteria:

* Tumors involving hollow viscera that are considered to have a clinically significant risk of bleeding or perforation.
* Patients with impaired consciousness or who are unable to care for themselves.

Conditions2

CancerRadiotherapy-Induced Immune Priming

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.